Topcon Healthcare Partners with Sanro Health to Unify Eye Data for Smarter Care

Smarter data, sharper vision. Topcon and Sanro team up to connect every pixel of eye care.

Oops, Topcon Healthcare (New Jersey, USA) did it again.

Straight off the heels of its Toku Inc. (California, USA) acquisition, Topcon has announced that it will invest in Sanro Health (Melbourne, Australia), making a bold step toward a connected, AI-ready ecosystem for ophthalmology.

The goal? To bring together ophthalmic clinical and imaging data within a single interoperable framework, making it accessible, actionable and more powerful for smarter diagnostics, faster research and more personalized patient care.

“Every patient’s history tells a story, but too often that story is fragmented,” said Dr. Ashley Kras, Sanro co-founder and CEO, in a news release. “Sanro connects and interprets data so clinicians can see the full picture and researchers act faster. With Topcon Healthcare’s support, we’re building the connected data infrastructure across eyecare providers that healthcare needs today.”

Bringing the data and expertise for smarter eye care

One of the biggest roadblocks in modern eye care has long been data fragmentation. Clinical records, diagnostic results and imaging data are often trapped in separate silos across different systems. A patient’s visual acuity chart might sit in one clinic’s electronic health record (EHR), while their optical coherence tomography (OCT) scans or fundus photos live on an entirely different platform.

This disconnect limits a clinician’s ability to see the patient’s complete visual history, complicating research and slowing clinical decision-making. It also hampers the push toward AI-powered, data-driven care, where every pixel and datapoint could make a difference.

Topcon and Sanro are tackling this problem head-on, combining their respective strengths in technology and clinical insights to create a unified, intelligent framework for eye care.

This collaboration builds on Topcon’s recent acquisition of Toku, a developer of non-invasive, AI-driven diagnostic and retinal imaging technology. The Toku acquisition further expands Topcon’s capabilities in AI-controlled image analysis and strengthens its position at the forefront of connected, data-enabled eye care.

Through these partnerships, Topcon gains access to real-world, contextualized data that can enhance its AI algorithms and accelerate the development of next generation diagnostic and management tools.

“By linking these data sets using agreed data standards, we can transform how patient care and research interconnect,” said Ali Tafreshi, president and CEO of Topcon.

Sanro, in turn, benefits from Topcon’s global reach, research networks and technological infrastructure, scaling its connected data platform to more eye care professionals worldwide.

More on Sanro Health

Founded by retina specialists Dr. Ashley Kras and Dr. Eddie Korot, Sanro Health was built on a mission to bridge the disconnect between data and clinical context. Its flagship platform, Sanro Optimizer, integrates EHR data—diagnosis, medications and visual acuity—with imaging data such as OCT and fundus images to create an intelligent patient profile.

By combining these datasets, the platform can:

Identify and rank patients based on specific disease characteristics
Recognize eligible participants for clinical trials in real time
Connect information across clinics while maintaining patient privacy and data integrity

This seamless integration reduces the need for eye care professionals to toggle between systems or manually reconcile imaging files, streamlining workflows and enabling faster, data-informed decisions.

More on Topcon Healthcare

Meanwhile, Topcon Healthcare brings nearly a century of innovation in ophthalmic imaging, AI-based diagnostics and teleophthalmology. The company’s long-term vision, Healthcare from the Eye, revolves around using the eye as a window to systemic health, capable of revealing early signs of diseases such as diabetes, hypertension and dementia through non-invasive imaging and analytics.

As Topcon deepens its investment in innovation, from a partnership with Sanro to its recent acquisition of Toku, the company continues to strengthen its vision to a more connected, AI-driven eye care.